Red man syndrome and the red button system: where next for inpatient adverse drug reaction reporting?
作者信息
Schiff G D
机构信息
General Medicine Clinic, Cook County Hospital, Chicago, USA.
出版信息
Jt Comm J Qual Improv. 1995 Oct;21(10):549-52. doi: 10.1016/s1070-3241(16)30181-x.
PMID:8556112
Abstract
摘要
相似文献
1
Red man syndrome and the red button system: where next for inpatient adverse drug reaction reporting?
Jt Comm J Qual Improv. 1995 Oct;21(10):549-52. doi: 10.1016/s1070-3241(16)30181-x.
2
The incident reporting system does not detect adverse drug events: a problem for quality improvement.事件报告系统无法检测到药物不良事件：这是质量改进中的一个问题。
Jt Comm J Qual Improv. 1995 Oct;21(10):541-8. doi: 10.1016/s1070-3241(16)30180-8.
3
10 targets for reducing adverse drug events. Institute for Healthcare Improvement.减少药物不良事件的10个目标。医疗改进研究所。
Qual Lett Healthc Lead. 1999 Mar;11(3):13-25.
4
A crystal ball for coding.
J AHIMA. 2000 Jan;71(1):26-33.
5
[Interpretation of adverse drug reaction reporting and monitoring and significance of traditional Chinese medicine adverse drug reaction monitoring].[药品不良反应报告和监测解读及中药不良反应监测的意义]
Zhongguo Zhong Yao Za Zhi. 2012 Sep;37(18):2686-8.
6
The fatal love of forms.对形式的致命热爱。
Drug Saf. 2011 Aug 1;34(8):705-7. doi: 10.2165/11595130-000000000-00000.
7
The adverse drug reaction: a clinical opportunity for pharmacists.药物不良反应：药剂师的临床机遇。
Hosp Pharm. 1995 Sep;30(9):769-73.
8
FDA approves mandatory risk management program for isotretinoin.美国食品药品监督管理局批准了异维A酸的强制性风险管理计划。
Dermatol Nurs. 2005 Oct;17(5):383.
9
Managing source system content in the EHR.在电子健康记录中管理源系统内容。
J AHIMA. 2008 Mar;79(3):60-1, 68.
10
An open letter to the FDA regarding changes in reporting procedures for drugs and biologics proposed in the wake of the FIAU tragedy.一封就氟碘阿糖脲苷（FIAU）悲剧后提议的药品和生物制品报告程序变更事宜致美国食品药品监督管理局（FDA）的公开信。
Control Clin Trials. 1996 Aug;17(4):273-84. doi: 10.1016/0197-2456(95)00257-x.
Zotero 插件